Amol Mujoomdar

820 total citations
33 papers, 435 citations indexed

About

Amol Mujoomdar is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Amol Mujoomdar has authored 33 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Epidemiology. Recurrent topics in Amol Mujoomdar's work include Radiation Dose and Imaging (6 papers), Liver Disease and Transplantation (5 papers) and Radiology practices and education (5 papers). Amol Mujoomdar is often cited by papers focused on Radiation Dose and Imaging (6 papers), Liver Disease and Transplantation (5 papers) and Radiology practices and education (5 papers). Amol Mujoomdar collaborates with scholars based in Canada, United States and Saudi Arabia. Amol Mujoomdar's co-authors include H. Raftopoulos, Charles A. Powell, John H. M. Austin, Maria C. Shiau, Gregory D. Pearson, Rebecca Zener, Melanie Beaton, Ellen Kao, Charles A. McKenzie and Francine Tremblay and has published in prestigious journals such as Radiology, IEEE Transactions on Medical Imaging and American Journal of Roentgenology.

In The Last Decade

Amol Mujoomdar

29 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amol Mujoomdar Canada 11 223 190 90 81 80 33 435
Nitin Shetty India 13 236 1.1× 192 1.0× 62 0.7× 202 2.5× 109 1.4× 73 551
Michael M. Wach United States 13 159 0.7× 127 0.7× 104 1.2× 147 1.8× 30 0.4× 34 380
Audrey Fohlen France 14 131 0.6× 82 0.4× 57 0.6× 264 3.3× 55 0.7× 41 535
Oleg Mironov Canada 12 119 0.5× 104 0.5× 49 0.5× 214 2.6× 53 0.7× 30 485
Zeljka Jutric United States 13 197 0.9× 373 2.0× 96 1.1× 331 4.1× 29 0.4× 40 559
Jacques P. Fontaine United States 15 449 2.0× 130 0.7× 22 0.2× 271 3.3× 70 0.9× 69 600
Shunsuke Sugawara Japan 11 134 0.6× 67 0.4× 41 0.5× 166 2.0× 35 0.4× 63 337
Tony Ibrahim Lebanon 11 89 0.4× 160 0.8× 22 0.2× 90 1.1× 46 0.6× 46 393
Olaguoke Akinwande United States 14 178 0.8× 160 0.8× 84 0.9× 307 3.8× 59 0.7× 43 574
Saboor Khan United Kingdom 12 244 1.1× 308 1.6× 98 1.1× 376 4.6× 20 0.3× 32 605

Countries citing papers authored by Amol Mujoomdar

Since Specialization
Citations

This map shows the geographic impact of Amol Mujoomdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol Mujoomdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol Mujoomdar more than expected).

Fields of papers citing papers by Amol Mujoomdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amol Mujoomdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol Mujoomdar. The network helps show where Amol Mujoomdar may publish in the future.

Co-authorship network of co-authors of Amol Mujoomdar

This figure shows the co-authorship network connecting the top 25 collaborators of Amol Mujoomdar. A scholar is included among the top collaborators of Amol Mujoomdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol Mujoomdar. Amol Mujoomdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mujoomdar, Amol, Derek W. Cool, Anouar Teriaky, et al.. (2025). Effectiveness of retrograde transvenous obliteration for primary prophylaxis of gastric variceal bleeding. PubMed. 8(1). 79–89.
3.
Cool, Derek W., et al.. (2024). Impact of Varicocele Embolization on DNA Fragmentation Index (DFI) in Male Infertility. Journal of Vascular and Interventional Radiology. 36(3). 472–476.
4.
Li, David & Amol Mujoomdar. (2024). Enhancing Radiation Safety Education During Medical Training: A Canadian Perspective. American Journal of Roentgenology. 224(1). e2432152–e2432152. 1 indexed citations
5.
Cool, Derek W., et al.. (2023). Proximal splenic artery embolization using a vascular plug in grade IV or V splenic trauma – a single centre 11-year experience. CVIR Endovascular. 6(1). 1–1. 2 indexed citations
6.
Wong, Jason K., Howard J. Lim, Vincent C. Tam, et al.. (2023). Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews. 115. 102526–102526. 3 indexed citations
7.
Wright, Christopher, et al.. (2022). Looking Into the Future: The Current and Future State of IR in Canada. Canadian Association of Radiologists Journal. 74(1). 211–216. 3 indexed citations
8.
Vogt, Kelly, Neil Parry, Fran Priestap, et al.. (2021). Retrievable inferior vena cava filter for primary prophylaxis of pulmonary embolism in at-risk trauma patients: A feasibility trial. Injury. 52(5). 1210–1214. 4 indexed citations
9.
Chung, C.Y., et al.. (2021). Percutaneous ultrasound gastrostomy (PUG): first prospective clinical trial. Abdominal Radiology. 46(11). 5377–5385. 3 indexed citations
10.
Sutherland, Duncan E. K., Rami M. Abazid, Amol Mujoomdar, et al.. (2021). Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS). Journal of Cancer Research and Clinical Oncology. 148(1). 225–236. 21 indexed citations
11.
Klass, Darren, et al.. (2020). Current Locoregional Therapies and Treatment Strategies in Hepatocellular Carcinoma. Current Oncology. 27(13). 144–151. 16 indexed citations
12.
Cool, Derek W., et al.. (2020). Nonmalignant Enhancement Following Percutaneous Renal Ablation Mimicking Viable Malignancy. CardioVascular and Interventional Radiology. 44(1). 176–178.
13.
Uum, Stan Van, et al.. (2020). Percutaneous Cryoablation of Recurrent Pancreatic Mass for Life-Threatening Pancreatic VIPoma Syndrome: A Case Report. CardioVascular and Interventional Radiology. 44(1). 163–166. 1 indexed citations
14.
Cool, Derek W., et al.. (2020). Percutaneous Ultrasound Gastrostomy: First-in-Human Experience with the PUMA-G System. Journal of Vascular and Interventional Radiology. 31(5). 808–811. 6 indexed citations
15.
Qumosani, Karim, et al.. (2019). A150 A RARE CASE OF OBSCURE GI BLEEDING SECONDARY TO ECTOPIC SMALL INTESTINAL VARICES POST ROUX-EN-Y GASTRIC BYPASS. Journal of the Canadian Association of Gastroenterology. 2(Supplement_2). 297–298.
17.
Zener, Rebecca, et al.. (2017). Transarterial embolization of intralobar pulmonary sequestration in a young adult with hemoptysis. Journal of Thoracic Disease. 9(3). E188–E193. 22 indexed citations
19.
Zener, Rebecca, et al.. (2016). Successful percutaneous CT-guided microwave ablation of adrenal gland for ectopic Cushing syndrome. Clinical Imaging. 42. 93–95. 7 indexed citations
20.
Lee, Kevin, Alexandra C. Istl, Luc Dubois, et al.. (2014). Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator. Journal of Vascular Surgery. 60(5). 1409–1410. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026